Allopurinol Protective Effect of Renal Ischemia by Downregulating TNF-α, IL-1β, and IL-6 Response

REFERENCES

• Devarajan P. Update on mechanisms of ischemic acute kidney injury. J Am Soc Nephrol. 2006;17:1503–1520.
   PubMed Web of Science ®Google Scholar
• Castaneda MP, Swiatecka-Urban A, Mitsnefes MM, et al. Activation of mitochondrial apoptotic pathways in human renal allografts after ischemia-reperfusion injury. Transplantation. 2003;76(1):50–54.
   PubMed Web of Science ®Google Scholar
• Kosieradzki M, Rowinski W. Ischemia/reperfusion injury in kidney transplantation: mechanisms and prevention. Transpl Proc. 2008;40:3279–3288.
   PubMed Web of Science ®Google Scholar
• Turley KR, Toledo-Pereyra LH, Kothari RU. Molecular mechanism in the pathogenesis and treatment of acute ischemic stroke. J Invest Surg. 2005;18(4):207–218.
   PubMed Web of Science ®Google Scholar
• Elion GBSW, Callahan SW, Hitchings GH, et al. Experimental clinical and metabolic studies of thiopurines. Cancer Chemother Rep. 1962;16:197–202.
   PubMedGoogle Scholar
• Pacher P, Nivorozhkin A, Szabó C. Therapeutic effects of xanthine oxidase inhibitors: Renaissance half a century after discovery of allopurinol. Pharmacol Rev. 2006;58:87–114.
   PubMed Web of Science ®Google Scholar
• Elion GB, Kovensky A, Hitchings GH. Metabolic studies of allopurinol, an inhibitor of xanthine oxidase. Biochem Pharmacol. 1966;15:863–880.
   PubMed Web of Science ®Google Scholar
• Suzuki I, Yamauchi T, Onuma M, et al. Allopurinol, an inhibitor of uric acid synthesis-can it be used for the treatment of metabolic syndrome and related disorders?. Drugs Today. 2009;45(5):363–378.
   PubMed Web of Science ®Google Scholar
• Murrel GAC, Rapeport WG. Clinical pharmacokinetics of allopurinol. Clin Pharmacokinet. 1986;11:343–353.
   PubMed Web of Science ®Google Scholar
• De wall RA, Vasko KA, Stanley EL, et al. Responses of the ischemic myocardium to allopurinol. Am Heart J. 1971;82:362–370.
   PubMed Web of Science ®Google Scholar
• Vasko KA, DeWall RA, Riley AM. Effect of allopurinol in renal ischemia. Surgery. 1972;71:787–790.
   PubMed Web of Science ®Google Scholar
• Godin DV, Bhimji S. Effects of allopurinol on myocardial ischemic injury induced by coronary artery ligation and reperfusion. Biochem Pharmacol. 1987;36:2101–2107.
   PubMed Web of Science ®Google Scholar
• Namazi MR. Cetirizine and allopurinol as novel weapons against cellular autoimmune disorders. Int Immunopharmacol. 2004;4(3):349–353.
   PubMed Web of Science ®Google Scholar
• Aricioglu A, Aydin S, Turkozkan N, et al. The effect of allopurinol on Na+K+ATPase related lipid peroxidation in ischemic and reperfused rabbit kidney. Gen Pharmacol. 1994;25(2):341–344.
   PubMedGoogle Scholar
• Zhang C, Hein TW, Wang W, et al. Activation of JNK and xanthine oxidase by TNF-alpha impairs nitric oxide-mediated dilation of coronary arterioles. J Mol Cell Cardiol. 2006;40(2):247–257.
   PubMed Web of Science ®Google Scholar
• Perry BC, Soltys D, Toledo AH, et al. Tumor necrosis factor-α in liver ischemia/reperfusion injury. J Invest Surg. 2011;24:178–188.
   PubMed Web of Science ®Google Scholar
• Netea MG, Kullberg BJ, Block WL, et al. The role of hyperuricemia in the increased cytokine production after lipopolysaccharide in neutropenic mice. Blood. 1997;89:577–582.
   PubMed Web of Science ®Google Scholar
• Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Annal Biochem. 1979;95:351–358.
   PubMed Web of Science ®Google Scholar
• Lowry OH, Rosengourgh NJ, Farr AL, et al. Protein measurement folin phenol reagent. J Biol Chem. 1951;192:265–275.
   Google Scholar
• Renlund DG. A quantitative and sensitive method for measurement of myeloperoxidase. Clin Res. 1980;28:75–81.
   Google Scholar
• Suzuki K, Ota H, Sasagawa S, et al. Assay method for myeloperoxidase in human polymorphonuclear leukocytes. Anal Biochem. 1983;132(2):345–352.
   PubMed Web of Science ®Google Scholar
• Pesce A. Lactate dehydrogenase. In: Clin Chem, Kaplan A et al. eds The C.V. Mosby co. St Louis. Toronto: Princeton; 1984:1124–1117.
   Google Scholar
• Griffith OW. Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal Biochem. 1980;106(1):207–212.
   PubMed Web of Science ®Google Scholar
• Chaney AL, Marbach EP. Modified reagents for determination of urea and ammonia. Clin Chem. 1962;8:130–132.
   PubMed Web of Science ®Google Scholar
• Butler AR. The Jaffé reaction. Identification of the coloured species. Clin Chim Acta. 1975;59(2):227–232.
   PubMed Web of Science ®Google Scholar
• Demfalk J, Persson Waller K, Johannisson A. The xMAP technique can be used for detection of the inflammatory cytokines IL-1β, IL-6 and TNF-alpha in bovine samples. Vet Immunol Immunopathol. 2007;118:40–49.
   PubMed Web of Science ®Google Scholar
• Ratcliffe PJ. From erythropoietin to oxygen: Hypoxia-inducible factor hydroxylases and the hypoxia signal pathway. Blood Purif. 2002;20(5):445–450.
   PubMed Web of Science ®Google Scholar
• Khazen W, M'bika JP, et al. Expression of macrophage-selective markers in human and rodent adipocytes. FEBS Lett. 2005;579(25):5631–5634.
   PubMed Web of Science ®Google Scholar
• Uetrecht JP. Myeloperoxidase as a generator of drug free radicals. Biochem Soc Symp. 1995;61:163–170.
   PubMedGoogle Scholar
• Ala-Kapee M, Nevanlinna H, Mali M, et al. Localization of gene for human syndecan, an integral membrane proteoglycan and a matrix receptor, to chromosome 2. Somat Cell Mol Genet. 1990;16(5):501–505.
   PubMedGoogle Scholar
• Monzen S, Yoshino H, Kasai-Eguchi K, et al. Characteristics of myeloid differentiation and maturation pathway derived from human hematopoietic stem cells exposed to different linear energy transfer radiation types. Plos One. 2013;8(3):e59385.
   Google Scholar
• Livolsi A, Busuttil V, Imbert V, et al. Tyrosine phosphorylation-dependent activation of Nf-kappa B. Requirement for p56 LCK and ZAP-70 protein tyrosine kinases. Eur J Biochem. 2001;268(5):1508–1515.
   PubMedGoogle Scholar
• Pastchan D, Pastchan S, Müller GA. Inflammation and microvasculopathy in renal ischemia reperfusion injury. J Traspl. 2012;2012:764154.
   Google Scholar
• Kinsey GR, Li L, Okusa MD. Inflammation in acute kidney injury. Nephron. 2008;109:e102–e107.
   Google Scholar
• Abuelo J. G. Normotensive ischemic acute renal failure. N Engl J Med. 2007;357:797–805.
   PubMed Web of Science ®Google Scholar
• Prieto-Moure B, Carabén-Redaño A, Aliena-Valero A, et al. Allopurinol in renal ischemia. J Invest Surg. 2014;27:304–316.
   PubMed Web of Science ®Google Scholar
• Ilhan H, Alatas O, Tokar B, et al. Effects of the anti-ICAM-1 monoclonal antibody, allopurinol, and methylene blue on intestinal reperfusion injury. J Pediatr Surg. 2003;38:1591–1595.
   PubMed Web of Science ®Google Scholar
• Taylor PC, Peters AM, Paleolog E, et al. Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor alpha blockade in patients with rheumatoid arthritis. Arthritis Rheum. 2000;43:38–47.
   PubMed Web of Science ®Google Scholar
• Hatano E. Tumor necrosis factor signaling in hepatocyte apoptosis. J Gastroenterol Hepatol. 2007;22(Supl 1):S43–S44.
   Google Scholar
• Wang T, Qiao S, Lei S, et al. N-acetylcysteine and allopurinol synergistically enhance cardiac adiponectin content and reduce myocardial reperfusion injury in diabetic rats. PLoS One. 2011;6(8):e23967.
   Google Scholar
• Zhang C, Hein TW, Wang W, et al. Activation of JNK and xanthine oxidase by TNF-alpha impairs nitric oxide-mediated dilation of coronary arterioles. J Mol Cell Cardiol. 2006;40(2):247–257.
   PubMed Web of Science ®Google Scholar
• Gao X, Zhang H, Belmadani S, et al. Role of TNF-alpha-induced reactive oxygen species in endothelial dysfunction during reperfusion injury. Am J Physiol Heart Circ Physiol 2008;295(69):H2242–H2249.
   Google Scholar
• Liu PG, He SQ, Zhang YH, et al. Protective effects of apocynin and allopurinol on ischemia/reperfusion-induced liver injury in mice. World J Gastroenterol. 2008;14(18):2832–2837.
   PubMed Web of Science ®Google Scholar
• Yamaguchi M, Okamoto K, Kusano T, et al. The effects of xanthine oxidoreductase inhibitors on oxidative stress markers following global brain ischemia reperfusion injury in C57BL/6 Mice. PLoS One. 2015;10(7):e0133980.
   Google Scholar
• Gomes RZ, Romanek GM, Przybycien M, et al. Evaluation of the effect of allopurinol as a protective factor in post ischemia and reperfusion inflammation in Wistar rats. Acta Cir Bras. 2016;31(2):126–132.
   PubMed Web of Science ®Google Scholar
• Strieter RM, Kunkel SL, Bone RC. Role of tumor necrosis factor-α in disease states and inflammation. Crit Care Med. 1993;21:S447–S463.
   PubMed Web of Science ®Google Scholar
• Wajant H, Pfizenmaier K, Scheurich P. Tumor necrosis factor signaling. Cell Death Differ. 2003;10(1):45–65.
   PubMed Web of Science ®Google Scholar
• Demirel U, Yalniz M, Aygün C, et al. Allopurinol ameliorates thioacetamide-induced acute liver failure by regulating cellular redox-sensitive transcription factors in rats. Inflammation. 2012;35(4):1549–1557.
   PubMed Web of Science ®Google Scholar
• Matsuno N, Obara H, Watanabe R, et al. Rewarming preservation by organ perfusion system for donation after cardiac death liver grafts in pigs. Transpl Proc. 2014;46(4):1095–1098.
   PubMed Web of Science ®Google Scholar